RJA
FBT icon

Raymond James & Associates’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Raymond James & Associates’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$13.4M Sell
77,934
-2,224
-3% -$368K 0.01% 1052
2024
Q2 		$12.3M Sell
80,158
-31,041
-28% -$4.66M 0.01% 1046
2024
Q1 		$17.1M Sell
111,199
-13,879
-11% -$2.12M 0.01% 846
2023
Q4 		$19.8M Sell
125,078
-495
-0.4% -$71.1K 0.01% 746
2023
Q3 		$18.4M Sell
125,573
-6,328
-5% -$964K 0.02% 720
2023
Q2 		$20.2M Sell
131,901
-18,956
-13% -$2.96M 0.02% 683
2023
Q1 		$23.4M Buy
150,857
+1,628
+1% +$256K 0.02% 619
2022
Q4 		$23M Buy
149,229
+29,981
+25% +$4.42M 0.02% 612
2022
Q3 		$15.7M Buy
119,248
+8,326
+8% +$1.17M 0.02% 726
2022
Q2 		$15M Sell
110,922
-8,908
-7% -$1.23M 0.01% 750
2022
Q1 		$17.9M Sell
119,830
-14,143
-11% -$2.09M 0.02% 758
2021
Q4 		$21.7M Sell
133,973
-15,688
-10% -$2.54M 0.02% 700
2021
Q3 		$24.9M Sell
149,661
-19,357
-11% -$3.31M 0.02% 597
2021
Q2 		$29.2M Sell
169,018
-37,819
-18% -$6.25M 0.03% 532
2021
Q1 		$33.2M Sell
206,837
-16,390
-7% -$2.81M 0.03% 446
2020
Q4 		$37.5M Sell
223,227
-2,380
-1% -$386K 0.04% 382
2020
Q3 		$35.5M Buy
225,607
+5,017
+2% +$820K 0.04% 347
2020
Q2 		$37M Buy
220,590
+41,179
+23% +$6.46M 0.05% 318
2020
Q1 		$23.5M Buy
179,411
+16,688
+10% +$2.38M 0.04% 399
2019
Q4 		$24.2M Sell
162,723
-8,673
-5% -$1.19M 0.03% 501
2019
Q3 		$21.2M Sell
171,396
-197,324
-54% -$26.3M 0.03% 520
2019
Q2 		$51.9M Buy
368,720
+31,046
+9% +$4.28M 0.07% 247
2019
Q1 		$50.9M Buy
337,674
+32,363
+11% +$4.66M 0.08% 241
2018
Q4 		$37.9M Buy
305,311
+2,695
+0.9% +$369K 0.07% 271
2018
Q3 		$48M Buy
302,616
+158,596
+110% +$24M 0.07% 241
2018
Q2 		$20.2M Buy
144,020
+14,642
+11% +$2.01M 0.03% 501
2018
Q1 		$17.2M Buy
129,378
+26,131
+25% +$3.57M 0.03% 532
2017
Q4 		$12.9M Buy
103,247
+2,763
+3% +$341K 0.02% 646
2017
Q3 		$12.5M Buy
100,484
+23,389
+30% +$2.77M 0.02% 633
2017
Q2 		$8.79M Sell
77,095
-4,681
-6% -$503K 0.02% 765
2017
Q1 		$8.61M Sell
81,776
-46,975
-36% -$4.71M 0.02% 756
2016
Q4 		$11.7M Buy
128,751
+24,918
+24% +$2.33M 0.03% 560
2016
Q3 		$10.4M Sell
103,833
-13,333
-11% -$1.31M 0.03% 589
2016
Q2 		$10.5M Sell
117,166
-11,242
-9% -$1.03M 0.03% 518
2016
Q1 		$11.2M Sell
128,408
-326,376
-72% -$28.7M 0.04% 482
2015
Q4 		$51.4M Sell
454,784
-37,181
-8% -$4M 0.18% 118
2015
Q3 		$49.8M Buy
491,965
+17,792
+4% +$2.12M 0.2% 101
2015
Q2 		$58.8M Buy
474,173
+96,678
+26% +$11.7M 0.23% 89
2015
Q1 		$44.6M Buy
377,495
+31,490
+9% +$3.56M 0.2% 101
2014
Q4 		$35.3M Sell
346,005
-2,551
-0.7% -$249K 0.17% 114
2014
Q3 		$32M Buy
348,556
+10,177
+3% +$883K 0.18% 97
2014
Q2 		$27.9M Buy
338,379
+34,308
+11% +$2.62M 0.17% 110
2014
Q1 		$23.3M Buy
304,071
+39,633
+15% +$3.09M 0.16% 129
2013
Q4 		$18.3M Buy
264,438
+116,042
+78% +$7.61M 0.14% 162
2013
Q3 		$9.62M Buy
148,396
+46,114
+45% +$2.92M 0.08% 271
2013
Q2 		$5.95M Buy
+102,282
New +$5.84M 0.06% 372

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Raymond James & Associates's FBT Position: Q3 2024 in Review

Raymond James & Associates reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.8% in Q3 2024, selling an estimated $368K and leaving 77,934 shares worth $13.4M. The position accounts for 0.01% of the portfolio, ranked #1052.

Raymond James & Associates first reported a position in FBT in Q2 2013 and has held it in 46 quarters since. The position peaked at $58.8M in Q2 2015. 257 funds tracked by Wall St. Rank hold FBT as of Q3 2024.

  • Raymond James & Associates held 77,934 shares of First Trust NYSE Arca Biotechnology Index Fund worth $13.4M as of Q3 2024.
  • Raymond James & Associates sold 2,224 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2024, an estimated $368K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1052 holding.
  • Raymond James & Associates first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's First Trust NYSE Arca Biotechnology Index Fund position peaked at $58.8M in Q2 2015.
  • 257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.